FDA Grants Emergency Use Authorization for New Monoclonal Antibody Treatment
The FDA on Saturday announced an emergency use authorization for a new monoclonal antibody treatment against COVID-19. The emergency use authorization for the new drug, called bebtelovimab, is for the treatment of “mild to moderate COVID-19 in adults and pediatric patients,” the FDA said Friday. This includes those with a positive virus test who are […]
The post FDA Grants Emergency Use Authorization for New Monoclonal Antibody Treatment appeared first on Human Events…
Read More
0
